Table 2.
Volume threshold | – | 2 cm3 | 3 cm3 | 4 cm3 | 5 cm3 | 6 cm3 | 7 cm3 |
---|---|---|---|---|---|---|---|
Number of patients (TTE — non‐TTE) | 38–61 | 34–58 | 31–45 | 25–41 | 24–37 | 19–32 | 17–26 |
Age | 0.315 | 0.514 | 0.696 | 0.604 | 0.614 | 0.643 | 0.149 |
Tumor volume at treatment | 0.527 | 0.513 | 0.142 | 0.332 | 0.191 | 0.254 | 0.121 |
Dose to 99% of the tumor volume | 0.152 | 0.145 | 0.094 | 0.126 | 0.204 | 0.202 | 0.301 |
Coverage | 0.581 | 0.739 | 0.590 | 0.681 | 0.672 | 0.993 | 0.782 |
Selectivity | 0.909 | 0.908 | 0.919 | 0.980 | 0.761 | 0.910 | 0.739 |
Gradient index | 0.383 | 0.443 | 0.248 | 0.280 | 0.225 | 0.378 | 0.595 |
Paddick conformity index | 0.961 | 0.989 | 0.954 | 0.932 | 0.774 | 0.740 | 0.757 |
Number of iso‐centers | 0.792 | 0.645 | 0.786 | 0.499 | 0.687 | 0.768 | 0.819 |
Beam‐on time | 0.548 | 0.630 | 0.550 | 0.853 | 0.504 | 0.611 | 0.990 |